Cat. No. 5395
Chemical Name: O-(2-Aminoethyl)-5Z,8Z,11Z,14Z-eico
Biological ActivityTFA salt of virodhamine, an endogenous cannabinoid receptor mixed agonist/antagonist that is found in higher concentrations peripherally than anandamide. Virodhamine is a full agonist at GPR55 and CB2 and partial agonist/antagonist at CB1 (EC50 values are 12, 381 and 2920 nM at GPR55, CB2 and CB1 receptors respectively).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Porter et al (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J.Pharmacol.Exp.Ther. 301 1020. PMID: 12023533.
If you know of a relevant reference for Virodhamine trifluoroacetate please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Virodhamine trifluoroacetate from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Virodhamine trifluoroacetate, supplier, Virodhamine, TFA, GPR55, CB2, agonists, CB1, partial, antagonists, non-selective, cannabinoids, receptors, cb2r, cb1r, Trifluoroacetic, acid, salt, Tocris Bioscience, Non-selective Cannabinoid products
Find multiple products by catalog number
New Products in this Area
Potent and selective CB2 partial agonist; orally biovailable
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.